NCT05204537View on ClinicalTrials.gov

The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

March 30, 2022

Conditions
Surgical ComplicationCOVID-19PneumothoraxEmpyema, PleuralAbscessHemothoraxThoracic
Interventions
PROCEDURE

Lung parenchyma resection

Lung parenchyma removal

PROCEDURE

Empyemectomy

Intrapleural cavity effusion removal, parietal pleura removal.

Trial Locations (9)

10016

Thoracic Surgery, NYU Langone Health, New York

20900

San Gerardo Hospital, Monza

Unknown

Thoracic Surgery, Hospital Federal do Andaraí, Rio de Janeiro

Sunrise hospital., Kochi

Thoracic Surgery, Sir Ganga Ram Hospital, New Delhi

Thoracic Surgery, ASST Spedali Civili, Brescia

Thoracic Surgery, San Camillo Forlanini Hospital., Roma

Thoracic Surgery, San Giovanni Battista Molinette Hospital, Turin

Thoracic Surgery, University College London Hospitals, London

All Listed Sponsors
collaborator

Azienda Ospedaliera San Gerardo di Monza

OTHER

lead

University of Milano Bicocca

OTHER

NCT05204537 - The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications | Biotech Hunter | Biotech Hunter